Debattama R Sen

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 25

Top Venues

Nature immunology

Nature

NPJ precision oncology

Proceedings of the National Academy of Sciences of the United States of America

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Harvard University

United States

PHD :: Immunology

Columbia University

United States

BSC :: Biomedical Engineering

Publications

Alex C Y Chen, Sneha Jaiswal, Daniela Martinez, Cansu Yerinde, Keely Ji, Velita Miranda, Megan E Fung, Sarah A Weiss, Maria Zschummel, Kazuhiro Taguchi, Christopher S Garris, Thorsten R Mempel, Nir Hacohen, Debattama R Sen
The aged tumor microenvironment limits T cell control of cancer. Nature immunology 25 (6) (2024)
Alex C Y Chen, Sneha Jaiswal, Daniela Martinez, Cansu Yerinde, Keely Ji, Velita Miranda, Megan E Fung, Sarah A Weiss, Maria Zschummel, Kazuhiro Taguchi, Christopher S Garris, Thorsten R Mempel, Nir Hacohen, Debattama R Sen
The aged tumor microenvironment limits T cell control of cancer. Nature immunology 25 (6) (2024)
Alex C Y Chen, Debattama R Sen
Hyperactive DCs redirect aged anti-tumor immunity. Cancer research (2024)
Sarah A Weiss, Amy Y Huang, Megan E Fung, Daniela Martinez, Alex C Y Chen, Thomas J LaSalle, Brian C Miller, Christopher D Scharer, Mudra Hegde, Thao H Nguyen, Jared H Rowe, Jossef F Osborn, Dillon G Patterson, Natalia Sifnugel, C Mei-An Nolan, Richard A Davidson, Marc Andre Schwartz, Alexander P R Bally, Dennis K Neeld, Martin W LaFleur, Jeremy M Boss, John G Doench, W Nicholas Haining, Arlene H Sharpe, Debattama R Sen
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control. Nature immunology (2024)
Alex C Y Chen, Sneha Jaiswal, Daniela Martinez, Cansu Yerinde, Keely Ji, Velita Miranda, Megan E Fung, Sarah A Weiss, Maria Zschummel, Kazuhiro Taguchi, Christopher S Garris, Thorsten R Mempel, Nir Hacohen, Debattama R Sen
The aged tumor microenvironment limits T cell control of cancer. Nature immunology (2024)
Alex C Y Chen, Sneha Jaiswal, Daniela Martinez, Cansu Yerinde, Keely Ji, Velita Miranda, Megan E Fung, Sarah A Weiss, Maria Zschummel, Kazuhiro Taguchi, Christopher S Garris, Thorsten R Mempel, Nir Hacohen, Debattama R Sen
The aged tumor microenvironment limits T cell control of cancer. Nature immunology 25 (6) (2024)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature (2023)
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Keith M Hamel, Kira E Olander, Thomas G R Davis, Kathleen A McGuire, Geoff T Halvorsen, Omar I Avila, Chirag H Patel, Sarah Y Kim, Ashwin V Kammula, Audrey J Muscato, Kyle Halliwill, Prasanthi Geda, Kelly L Klinge, Zhaoming Xiong, Ryan Duggan, Liang Mu, Mitchell D Yeary, James C Patti, Tyler M Balon, Rebecca Mathew, Carey Backus, Domenick E Kennedy, Angeline Chen, Kenton Longenecker, Joseph T Klahn, Cara L Hrusch, Navasona Krishnan, Charles W Hutchins, Jax P Dunning, Marinka Bulic, Payal Tiwari, Kayla J Colvin, Cun Lan Chuong, Ian C Kohnle, Matthew G Rees, Andrew Boghossian, Melissa A Ronan, Jennifer A Roth, Meng-Ju Wu, Juliette S M T Suermondt, Nelson H Knudsen, Collins K Cheruiyot, Debattama R Sen, Gabriel K Griffin, Todd R Golub, Nabeel El-Bardeesy, Joshua H Decker, Yi Yang, Magali Guffroy, Stacey Fossey, Patricia Trusk, Im-Meng Sun, Yue Liu, Wei Qiu, Qi Sun, Marcia N Paddock, Elliot P Farney, Mark A Matulenko, Clay Beauregard, Jennifer M Frost, Kathleen B Yates, Philip R Kym, Robert T Manguso
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity. Nature (2023)
Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature 615 (7950) (2023)
Manuel Alfredo Podestà, Cecilia B Cavazzoni, Benjamin L Hanson, Elsa D Bechu, Garyfallia Ralli, Rachel L Clement, Hengcheng Zhang, Pragya Chandrakar, Jeong-Mi Lee, Tamara Reyes-Robles, Reza Abdi, Alos Diallo, Debattama R Sen, Peter T Sage
Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states. Nature communications 14 (1) (2023)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature 615 (7950) (2023)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature 615 (7950) (2023)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature (2023)
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A Michaud, Rodrigo Saad-Beretta, Kathleen B Yates, Arvin Iracheta-Vellve, Johan K E Spetz, Xingping Qin, Kristopher A Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y Su, Angelina M Cicerchia, Martin Q Rasmussen, Samuel J Klempner, Dejan Juric, Sara I Pai, David M Miller, Anita Giobbie-Hurder, Jonathan H Chen, Karin Pelka, Dennie T Frederick, Susanna Stinson, Elena Ivanova, Amir R Aref, Cloud P Paweletz, David A Barbie, Debattama R Sen, David E Fisher, Ryan B Corcoran, Nir Hacohen, Peter Karl Sorger, Keith T Flaherty, Genevieve M Boland, Robert T Manguso, Russell William Jenkins
Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature (2023)
Pierre Tonnerre, David Wolski, Sonu Subudhi, Jihad Aljabban, Ruben C Hoogeveen, Marcos Damasio, Hannah K Drescher, Lea M Bartsch, Damien C Tully, Debattama R Sen, David J Bean, Joelle Brown, Almudena Torres-Cornejo, Maxwell Robidoux, Daniel Kvistad, Nadia Alatrakchi, Ang Cui, David J Lieb, James A Cheney, Jenna Gustafson, Lia L Lewis-Ximenez, Lucile Massenet-Regad, Thomas M Eisenhaure, Jasneet Aneja, W Nicholas Haining, Raymond T Chung, Nir Hacohen, Todd M Allen, Arthur Y Kim, Georg Michael Lauer
Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory. Nature immunology 22 (8) (2021)
Kathleen B Yates, Pierre Tonnerre, Genevieve E Martin, Ulrike Gerdemann, Rose Al Abosy, Dawn E Comstock, Sarah A Weiss, David Wolski, Damien C Tully, Raymond T Chung, Todd M Allen, Arthur Y Kim, Sarah Fidler, Julie Fox, John Frater, Georg Michael Lauer, W Nicholas Haining, Debattama R Sen
Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans. Nature immunology 22 (8) (2021)
Elise Alspach, Ryan D Chow, Shadhmer Demehri, Jennifer L Guerriero, Shashi Gujar, Felix J Hartmann, Beth A Helmink, William H Hudson, Won Jin Ho, Leyuan Ma, Barbara B Maier, Vivien I Maltez, Brian C Miller, Amy E Moran, Erin M Parry, Padmini S Pillai, Sarwish Rafiq, Miguel Reina-Campos, Pamela C Rosato, Nils-Petter Rudqvist, Megan K Ruhland, Idit Sagiv-Barfi, Avinash Das Sahu, Robert M Samstein, Christian M Schürch, Debattama R Sen, Daniela S Thommen, Yochai Wolf, Roberta Zappasodi
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research. Cancer immunology research 9 (11) (2021)
Ivy X Chen, Kathleen Newcomer, Kristen E Pauken, Vikram R Juneja, Kamila Naxerova, Michelle W Wu, Matthias Pinter, Debattama R Sen, Meromit Singer, Arlene H Sharpe, Rakesh K Jain
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade. Proceedings of the National Academy of Sciences of the United States of America 117 (38) (2020)
Vinidhra Mani, Shannon K Bromley, Tarmo Äijö, Rut Mora-Buch, Esteban Carrizosa, Ross D Warner, Moustafa Hamze, Debattama R Sen, Alexandra Y Chasse, Alina Lorant, Jason W Griffith, Rod A Rahimi, Craig P McEntee, Kate L Jeffrey, Francesco Marangoni, Mark A Travis, Adam Lacy-Hulbert, Andrew D Luster, Thorsten R Mempel
Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science (New York, N.Y.) 366 (6462) (2020)
Brian C Miller, Debattama R Sen, Rose Al Abosy, Kevin Bi, Yamini V Virkud, Martin W LaFleur, Kathleen B Yates, Ana Lako, Kristen Felt, Girish S Naik, Michael Manos, Evisa Gjini, Juhi R Kuchroo, Jeffrey J Ishizuka, Jenna L Collier, Gabriel K Griffin, Seth Maleri, Dawn E Comstock, Sarah A Weiss, Flavian D Brown, Arpit Panda, Margaret D Zimmer, Robert T Manguso, F Stephen Hodi, Scott J Rodig, Arlene H Sharpe, W Nicholas Haining
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nature immunology 20 (3) (2019)
Flavian D Brown, Debattama R Sen, Martin W LaFleur, Jernej Godec, Veronika Lukacs-Kornek, Frank Alexander Schildberg, Hye-Jung Kim, Kathleen B Yates, Stéphane J H Ricoult, Kevin Bi, Justin D Trombley, Varun N Kapoor, Illana A Stanley, Viviana Cremasco, Nika N Danial, Brendan D Manning, Arlene H Sharpe, W Nicholas Haining, Shannon J Turley
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nature immunology 20 (12) (2019)
Peter T Sage, Noga Ron-Harel, Vikram R Juneja, Debattama R Sen, Seth Maleri, Waradon Sungnak, Vijay K Kuchroo, W Nicholas Haining, Nicolas Chevrier, Marcia Haigis, Arlene H Sharpe
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function. Nature immunology 17 (12) (2016)

Debattama R Sen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Debattama R Sen